Endothelial cell activation in inflammation: Lessons from mutant mouse models

Pathophysiology

Volumn 9, Issue 2, 2003, Pages 63-74

  Kevil, Christopher G ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Adhesion molecule; Cardiovascular disease; Endothelium; eNOS; Gene targeted mutation

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE SYNTHASE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL ADHESION; ENDOTHELIUM CELL; GENE MUTATION; GENE TARGETING; INFLAMMATION; LEUKOCYTE ADHERENCE; MUTANT; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; TISSUE SPECIFICITY; VASCULAR ENDOTHELIUM;

EID: 0142218324     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928468002000834     Document Type: Article

References (100)

1. Ross R. Cell biology of atherosclerosis. Ann. Rev. Physiol. 1995;57.
2. Granger D.N., Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J. Leuk. Biol. 55:1994;662-675.
3. Consentino F., Rubattu S., Savoia C., Venturelli V., Pagannonne E., Volpe M. Endothelial dysfunction and stroke. J. Cardiovasc. Pharm. 38:2001;S75-S78.
4. Kevil C.G., Bullard D.C. Roles of Leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis. Am. J. Med. 106:1999;677-687.
5. Bullard D.C. Knockout mice in inflammation and research. Ley K. Physiology of Inflammation. 2000;381-401 Oxford University Press, New York.
6. Carmeliet P., Collen D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190:2000;387-405.
7. Kvietys P.R., Granger D.N. Endothelial cell monolayers as a tool for studying microvascular pathophysiology. Am. J. Physiol. 273:1997;G1189-G1199.
8. Kevil C.G., Bullard D.C. In vitro culture and characterization of gene targeted mouse endothelium. Acta Physiol. Scand. 173:2001;151-157.
9. Reiss Y., Hoch G., Deutsch U., Engelhardt B. T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur. J. Immunol. 28:1998;3086-3099.
10. Reiss Y., Engelhardt B. T cell interaction with ICAM-1-deficient endothelium in vitro: transendothelial migration of different T cell populations is mediated by endothelial ICAM-1 and ICAM-2. Int. Immunol. 11:1999;1527-1539.
11. M.P. Bevilacqua, J.S. Pober, D.L. Mendrick, R.S. Cotran, M.A. Gimbrone, Identification of an inducible endothelial-leukocyte adhesion molecule Proc. Natl. Acad. Sci. USA, 84 (1987) 9238-9242.
12. Gallatin W.M., Weissman I.L., Butcher E.C. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature. 304:1983;30-34.
13. Hsu-Lin S., Berman C.L., Furie B.C., August D., Furie B. A platelet membrane protein expressed during platelet activation and secretion. J. Biol. Chem. 259:1984;9121-9126.
14. McEver R.P., Beckstead J.H., Moore K.L., Marshall-Carlson L., Bainton D.F. GMP-140, a platelet alpha granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J. Clin. Invest. 84:1989;92-99.
15. Frenette P.S., Johnson R.C., Hynes R.O., Wagner D.D. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc. Natl. Acad. Sci. USA. 92:1995;7450-7454.
16. Frenette P.S., Wagner D.D. Insights into selectin function from knockout mice. Thromb. Haemostasis. 78:1997;60-64.
17. Frenette P.S., Moyna C., Hartwell D.W., Lowe J.B., Hynes R.O., Wagner D.D. Platelet-endothelial interactions in inflammed mesenteric venules. Blood. 91:1998;1318-1324.
18. Jung U., Bullard D.C., Tedder T.F., Ley K. Velocity differences between L- and P-selectin-dependent neutrophil rolling in venules of mouse cremaster muscle in vivo. Am. J. Physiol. 271:1996;H2740-H2747.
19. Mayadas T.N., Johnson R.C., Rayburn H., Hynes R.O., Wagner D.D. Leukocyte rolling and extravasion are severely compromised in p selectin deficient mice. Cell. 74:1993;541-554.
20. Hartwell D.W., Mayadas T.N., Berger G., Frenette P.S., Rayburn H., Hynes R.O., Wagner D.D. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory response. J. Cell. Biol. 143:1998;1129-1141.
21. Subramaniam M., Saffaripour S., Watson S.R., Mayadas T.N., Hynes R.O., Wagner D.D. Reduced recruitment of inflammatory cells in a contact hypersensitive response in p-selectin-deficient mice. J. Exp. Med. 181:1995;2277-2282.
22. Wickel D.J., Mercer-Jones M., Peyton J.C., Shrotri M.S., Cheadle W.G. Neutrophil migration into the peritonium is p-selectin dependent, but sequestration in lungs is selectin independent during peritonitis. Shock. 10:1998;265-269.
23. Singbartl K., Green S.A., Ley K. Blocking p-selectin protects ischemia/reperfusion-induced acute renal failure. FASEB J. 14:2000;48-54.
24. Kanwar S., Bullard D.C., Hicky M.J., Smith C.W., Beaudet A.L., Wolitzky B.A., Kubes P. The association between a4-integrin, p-selectin, and e-selectin in an allergic model of inflammation. J. Exp. Med. 185:1997;1077-1087.
25. Jones S.P., Trocha S.D., Strange M.B., Granger D.N., Kevil C.G., Bullard D.C., Lefer D.J. Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury. Am. J. Physiol. 279:2000;H2196-H2201.
26. Johnson R.C., Chapman S.M., Dong Z.M., Ordovas J.M., Mayadas T.M., Herz J., Hynes R.O., Schaefer E.J., Wagner D.D. Absence of P-selectin delays fatty streak formation in mice. J. Clin. Invest. 99:1997;1037-1043.
27. Johnson R.C., Mayadas T.N., Frenette P.S., Subramaniam R., Lacasce A., Hynes R.O., Wagner D.D. Blood cell dynamics in p-selectin-deficient mice. Blood. 86:1995;1106-1114.
28. Dong Z.M., Brown A.A., Wagner D.D. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation. 101:2000;2290-2295.
29. Dong Z.M., Chapman S.M., Brown A.A., Frenette P.S., Hynes R.O., Wagner D.D. The combined role of p- and e-selectins in atherosclerosis. J. Clin. Invest. 102:1998;145-152.
30. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., Beaudet A.L. P-selectin or intercellular adhesion molecule-1 deficiency substantially protects against atherosclerosis in apolipoprotein e-deficient mice. J. Exp. Med. 191:2000;189-194.
31. Mizgerd J.P., Meek B.B., Kutkoski G.J., Bullard D.C., Beaudet A.L., Doerschuk C.M. Selectins and neutrophil traffic: margination and streptococcus pnuemoniae-induced emigration in murine lungs. J. Exp. Med. 184:1996;639-645.
32. Soriano S.G., Wang Y.F., Wagner D.D., Frenette P.S. P- and E-selectin-deficient mice are susceptible to cerebral ischemia-reperfusion injury. Brain Res. 835:1999;360-364.
33. Wong J., Johnson B., Lee S.S., Bullard D.C., Smith C.W., Beaudet A.L., Kubes P. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J. Clin. Invest. 99:1997;2782-2790.
34. Barkalow F.J., Goodman M.J., Gerritsen M.E., Mayadas T.N. Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion. Blood. 88:1996;4585-4593.
35. Seiler K.P., Ma Y., Weis J.H., Frenette P.S., Hynes R.O., Wagner D.D., Weis J.J. E and P selectins are not required for resistance to severe murine lyme arthritis. Infect. Immun. 66:1998;4557-4559.
36. Rosenkrantz A.R., Mendrick D.L., Cotran R.S., Mayadas T.N. P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation. J. Clin. Invest. 103:1999;649-659.
37. Mayadas T.N., Mendrick D.L., Brady H.R., Tang T., Papayianni A., Assmann K.J.M., Wagner D.D., Hynes R.O., Cotran R.S. Acute passive anti-glomerular basement membrane nephritis in P-selectin deficient mice. Kidney Int. 49:1996;1342-1349.
38. Hickey M.J., Bullard D.C., Issekutz A., James W.G. Leukocyte-endothelial cell interactions are enhanced in dermal postcapillary venules of MRL/faslpr (lupus-prone) mice: roles of P and E-selectin. J. Immunol. 168:2002;4728-4736.
39. Homiester J.W., Zhang M., Frenette P.S., Hynes R.O., Wagner D.D., Lowe J.B., Marks R.M. Overlapping functions of e- and p-selectin in nuetrophil recruitment during acute inflammation. Blood. 92:1998;2345-2352.
40. Kunkel E.J., Ley K. Distinct phenotype of e-selectin-deficient mice: E-selectin is required for slow leukocyte rolling in vivo. Circ. Res. 79:1996;1196-1204.
41. Ley K., Allietta M., Bullard D.C., Morgan S. Importance of E-selectin for firm leukocyte adhesion in vivo. Circ. Res. 83:1998;287-294.
42. Lorenzon P., Vecile E., Nardon E., Ferrero E., Harlan J.M., Tedesco F., Dobrina A. Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. J. Cell. Biol. 142:1998;1381-1391.
43. Bullard D.C., Kunkel E.J., Kubo H., Hicks M.J., Lorenzo I., Doyle N.A., Doerschuk C.M., Ley K., Beaudet A.L. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in e-selectin and p-selectin double mutant mice. J. Exp. Med. 183:1996;2329-2336.
44. Frenette P.S., Mayadas T.N., Rayburn H., Hynes R.O., Wagner D.D. Susceptibility to infection and altered hematopoiesis in mice deficient in both p- and e-selectins. Cell. 84:1996;563-574.
45. Munoz F.M., Hawkins E.P., Bullard D.C., Beaudet A.L., Kaplan S.L. Host defense against systemic infection with streptococcus pneumoniae is impaired in e-, p-, and e-/p-selectin-deficient mice. J. Clin. Invest. 100:1997;2099-2106.
46. Jung U., Ley K. Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. J. Immunol. 162:1999;6755-6762.
47. Robinson S.D., Frenette P.S., Rayburn H., Cummiskey M., Ullman-Cullere M., Wagner D.D., Hynes R.O. Multiple, targeted deficiencies in selectins reveal a predominant role for p-selectin in leukocyte recruitment. Proc. Natl. Acad. Sci. USA. 96:1999;11452-11457.
48. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
49. Lawson C., Ainsworth M., Yacoub M., Rose M. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappaB-independent mechanism. J. Immunol. 162:1999;2990-2996.
50. Pluskota E., Chen Y., D'Souza S.E. Src homology domain 2-containing tyrosine phosphatase 2 associates with intercellular adhesion molecule 1 to regulate cell survival. J. Biol. Chem. 275:2000;30029-30036.
51. Pluskota E., D'Souza S.E. Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival. Eur. J. Biochem. 267:2000;4693-4704.
52. Sligh J.E., Ballantyne C.M., Rich S.S., Hawkins H.K., Smith C.W., Bradley A., Beaudet A.L. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 90:1993;8529-8533.
53. Xu H., Gonzalo J.A., Pierre Y.S., Williams I.R., Kupper T.S., Cotran R.S., Springer T.A., Gutierrez-Ramos J.-C. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 180:1994;95-109.
54. King P.D., Sandberg E.T., Selvakumar A., Fang P., Beaudet A.L., Dupont B. Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative RNA splicing. J. Immunol. 154:1995;6080-6093.
55. Komatsu S., Flores S., Gerritsen M.E., Anderson D.C., Granger D.N. Differential up-regulation of circulating soluble and endothelial cell intercellular adhesion molecule-1 in mice. Am. J. Pathol. 151:1997;205-214.
56. Engel N.K.v.D., Heidenthal E., Vinke A., Kolb H., Martin S. Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1. Blood. 95:2000;1350-1355.
57. -/-) fed a fat or chow diet. Arterioscl. Thromb. Vasc. Biol. 20:2000;2630-2635.
58. Dietrich H., Hu Y., Zou Y., Dirnhofer S., Kliendienst R., Wick G., Xu Q. Mouse model of transplant arteriosclerosis: role of intercellular adhesion molecule-1. Arterioscl. Thromb. Vasc. Biol. 20:2000;343-352.
59. Nageh M.F., Sandberg E.T., Marotti K.R., Lin A.H., Melchior E.P., Bullard D.C., Beaudet A.L. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscl. Thromb. Vasc. Biol. 17:1997;1517-1520.
60. Connolly E.S., Winfree C.J., Springer T.A., Naka Y., Liao H., Yan S.D., Stem D.M., Solomon R.A., Gutierrez-Ramos J.-C., Pinksy D.J. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. J. Clin. Invest. 97:1996;209-216.
61. Kitagawa K., Matsumoto M., Mabuchi T., Yagita Y., Ohtsuki T., Hori M., Yanagihara T. Deficiency of intercellular adhesion molecule-1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia. J. Cerebr. Blood F. Met. 18:1998;1336-1345.
62. Kelly K.J., Williams W.W., Colvin R.B., Meehan S.M., Springer T.A., Gutierrez-Ramos J.-C., Bonventre J.V. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Invest. 97:1996;1056-1063.
63. Palazzo A.J., Jones S.P., Girod W.G., Anderson D.C., Granger D.N., Lefer D.J. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1 deficient mice. Am. J. Physiol. 275:1998;H2300-H2307.
64. Soriano S.G., Lipton S.A., Wang Y.F., Xiao M., Springer T.A., Gutierrez-Ramos J.-C., Hickey P.R. Intercellular adhesion molecule-1 deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann. Neurol. 39:1996;618-624.
65. P.M. Bendjelloul, V. Mandys, M. Jirkovska, L. Prokesova, L. Tuckova, H. Tlaskalova-Hogenova, Intercellular adhesion molecule-1 (ICAM-1) deficiency protects mice against severe forms of experimentally induced colitis. Clin. Exp. Immunol., 119 (2000) 57-63.
66. Bullard D.C., Hurley L.A., Lorenzo I., Sly L.M., Beaudet A.L., Staite N.D. Reduced susceptibility to collagen-induced arthritis in mice deficient in intercellular adhesion molecule-1. J. Immunol. 157:1996;3153-3158.
67. Bullard D.C., King P.D., Hicks M.J., Dupont B., Beudet A.L., Elkon K.B. Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Faslpr mice from early lethality. J. Immunol. 159:1997;2058-2067.
68. Samoilova E.B., Horton J.L., Chen Y. Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1 deficient mice. Cell. Immunol. 190:1998;83-89.
69. Broide D.H., Humber D., Sriramarao P. Inhibition of eosinophil rolling and recruitment in P-selectin and intracellular adhesion molecule-l-deficient mice. Blood. 91:1998;2847-2856.
70. Foy D.S., Ley K. Intercellular adhesion molecule-1 is required for chemoattractant-induced leukocyte adhesion in resting, but not inflamed venules in vivo. Microvasc. Res. 60:2000;249-260.
71. Kevil C.G., Patel R.P., Bullard D.C. Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells. Am. J. Physiol. 281:2001;C1442-C1447.
72. Steeber D.A., Campbell M.A., Basit A., Ley K., Tedder T.F. Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc. Natl. Acad. Sci. USA. 95:1998;7562-7567.
73. deFougerolles A.R., Stacker S.A., Schwarting R., Springer T.A. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J. Exp. Med. 174:1991;253-267.
74. Gerwin N., Gonzalo J.-A., Lloyd C., Coyle A.J., Reiss Y., Banu N., Wang B., Xu H., Avraham H., Engelhardt B., Springer T.A., Gutierrez-Ramos J.C. Prolonged eosinophil accumulation in allergic lung interstitium of ICAM-2-deficient mice results in extended hyperresponsiveness. Immunity. 10:1999;9-19.
75. Taooka Y., Chen J., Yednock T., Sheppard D. The integrin a9b1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J. Cell. Biol. 145:1999;413-420.
76. Kwee L., Baldwin H.S., Shen H.M., Stewart C.L., Buck C., Buck C.A., Labow M.A. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development. 121:1995;489-503.
77. Terry R.W., Kwee L., Baldwin H.S., Labow M.A. Cre-mediated generation of a VCAM-1 null allele in transgenic mice. Transgen. Res. 6:1997;349-356.
78. Koni P.A., Joshi S.K., Temann U.-A., Olson D., Burkly L., Flavell R.A. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 193:2001;741-753.
79. Leuker C.E., Labow M., Muller W., Wagner N. Neonatally induce inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response. J. Exp. Med. 193:2001;755-767.
80. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.-C., Connelly P.W., Milstone D.S. A major role for VCAM-1, but not ICAM-1 in early atherosclerosis. J. Clin. Invest. 107:2001;1255-1262.
81. Dansky H.M., Barlow C.B., Lominska C., Sikes J.L., Kao C., Weinsaft J., Cybulsky M.I., Smith J.D. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscl. Thromb. Vasc. Biol. 21:2001;1662-1667.
82. Newman P.J. Cell adhesion in vascular biology: the biology of PECAM-1. J. Clin. Invest. 100:1997;S25-S29.
83. Bird I.N., Taylor V., Newton J.P., Spragg J.H., Simmons D.L., Salmon M., Buckley C.D. Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. J. Cell. Sci. 112:(Part 12):1999;1989-1997.
84. Duncan G.S., Andrew D.P., Takimoto H., Kaufman S.A., Yoshida H., Spellberg J., Pompa J.L.d.l., Elia A., Wakeham A., Karan-Tamir B., Muller W.A., Senaldi G., Zukowski M.M., Mak T.W. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-Independent functions. J. Immunol. 162:1999;3022-3030.
85. Thompson R.D., Noble K.E., Larbi K.Y., Dewar A., Duncan G.S., Mak T.W., Nourshargh S. Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood. 97:2001;1854-1860.
86. Graesser D., Solowiej A., Bruckner M., Osterweil E., Juedes A., Davis S., Ruddle N.H., Engelhardt B., Madri J.A. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109:2002;383-392.
87. Forlow S.B., White E.J., Barlow S.C., Feldman S.H., Lu H., Bagby G.J., Beaudet A.L., Bullard D.C., Ley K. Severe inflammatory defect and reduced viability in CD18 and E-selectin double-mutant mice. J. Clin. Invest. 106:2000;1457-1466.
88. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure function and inhibition. Biochem. J. 357:2001;593-615.
89. Govers R., Rabelink T.J. Celluar regulation of endothelial nitric oxide synthase. Am. J. Physiol. 280:2001;F193-F206.
90. Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., Fishman M.C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:1995;239-242.
91. Shesely E.G., Maeda N., Kim H.S., Desai K.M., Krege J.H., Laubach V.E., Sherman P.A., Sessa W.C., Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 93:1996;13176-13181.
92. Lefer D.J., Jones S.P., Girod W.G., Baines A., Grisham M.B., Cockrell A.S., Huang P.L., Scalia R. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am. J. Physiol. 276:1999;H1943-H1950.
93. -/- mice are ameliorated by enalapril treatment. J. Clin. Invest. 105:2000;451-458.
94. Kuhlencordt P.J., Gyurko T., Han F., Scherrer-Crosbie M., Aretz T.H., Hajjar T., Picard M.H., Huang P.L. Accelerated atherosclerosis, aortic aneurysm formation and ischemic heart disease in apolipoprotein e/endothelial nitric oxide synthase double-knockout mice. Circulation. 104:2001;448-454.
95. Shi W., Wang X., Shih D.M., Laubach V.E., Navab M., Lusis A.J. Paradoxical reduction of fatty streak formation in mice lacking endothelial nitric oxide synthase. Circulation. 105:2002;2078-2082.
96. Ozaki M., Kawashima S., Yamashita T., Hirase T., Namiki M., Inoue N., Hirata K.-i., Yasui H., Sakurai H., Yoshida Y., Masada M., Yokoyama M. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J. Clin. Invest. 110:2002;331-340.
97. S. Kanno, P.C. Lee, Y. Zhang, C. Ho, B.P. Griffith, L.L.S., T.R. Billiar, Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation 101 (2000) 2742-2748.
98. Sharp B.R., Jones S.P., Rimmer D.M., Lefer D.J. Differential response to myocardial reperfusion injury in eNOS-deficient mice. Am. J. Physiol. 282:2002;H2422-H2426.
99. Eppihimer M.J., Russell J., Anderson D.C., Wolitzky B.A., Granger D.N. Endothelial cell adhesion molecule expression in gene-targeted mice. Am. J. Physiol. 273:1997;H1903-H1908.
100. Ryding A.D.S., Sharp M.G.F., Mullins J.J. Conditional transgenic technologies. J. Endocrinol. 2001;1-14.